LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
Clinical trial NCT04479241 · COMPLETED
Trial details
- NCT number
- NCT04479241
- Sponsor
- Istari Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-21
- Primary completion
- 2024-06-05
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.